Evidence map›Paper›PMID 32055989›Full record

ArticleMikrochimica acta2020

Colorimetric aggregation assay based on array of gold and silver nanoparticles for simultaneous analysis of aflatoxins, ochratoxin and zearalenone by using chemometric analysis and paper based analytical devices.

Azarmidokht Sheini

Abstract read
PubMed Publisher
In one paragraph

Article in Mikrochimica acta, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
4.3field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 66 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Review
  13. Review
  14. Review
  15. Article
  16. Review
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Azarmidokht SheiniDepartment of Mechanical Engineering, Shohadaye Hoveizeh University of Technology, Susangerd, 78986, Iran. noyanchem2019@gmail.com.
Shomal University · IR

Funding

Ahvaz Jundishapur University of Medical Sciences -Shohadaye hoveizeh university of technology -
6 · The paper itself

Abstract

A paper based sensor array is presented to discriminate and determine five mycotoxins classified into three categories, namely aflatoxins, ochratoxins and zearalenone. The gold and silver nanoparticles, synthesized by three different reducing or capping agents, were employed as sensing elements of the fabricated device. These nanoparticles were poured onto hydrophilic circular zones embedded on the hydrophobic substrate. The response of the assay is dependent on the aggregation of nanoparticles for interaction with mycotoxins. Due to aggregation, the gold and silver nanoparticles changed to purple and brown, respectively. Color changes provide unique colorimetric signatures conducive to recognizing the type of mycotoxin, identifying its chemical structure, and finding the fungi that produce it. The discrimination ability of the assay was investigated by both supervised (linear discriminate analysis) and unsupervised (principle component analysis and hierarchical cluster analysis) pattern recognition methods. The assay was applied to the point of need determination of aflatoxin B1, aflatoxin G1, aflatoxin M1, ochratoxin A and zearalenone with a detection limit of 2.7, 7.3, 2.1, 3.3 and 7.0 ng.mL

Indexed as

AflatoxinsColorimetryGoldHumansMetal NanoparticlesOchratoxinsPaperSilverZearalenoneAflatoxinsGoldochratoxin AOchratoxinsSilverZearalenoneColorimetric sensor arrayFood qualityMycotoxinPaper based sensorStatistical analysis

Identifiers

PMID32055989
OpenAlexW3005725508

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.